Search Results - David E. Nichols
- Showing 1 - 20 results of 24
- Go to Next Page
-
1
-
2
-
3
-
4
The History of Psychedelics in Psychiatry by David E. Nichols, Hannes Walter
Published 2020Artigo -
5
-
6
5-HT2A Receptors: Pharmacology and Functional Selectivity by Benjamin Cummins, Gerald Billac, David E. Nichols, Charles D. Nichols
Published 2025Revisão -
7
-
8
-
9
High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO): A high-affinity 5-HT2A receptor-selective agonist radioligand by David E. Nichols, Stewart Frescas, Benjamin R. Chemel, Kenneth Rehder, Desong Zhong, Anita H. Lewin
Published 2008Artigo -
10
<i>N</i>-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT<sub>2</sub> Receptor Family Agonists and Comparison with a Series of Phenethylamine Analogues by David E. Nichols, Maria F. Sassano, Adam L. Halberstadt, Landon M. Klein, Simon D. Brandt, Simon Elliott, Wolfgang Fiedler
Published 2014Artigo -
11
-
12
-
13
-
14
Extensive Rigid Analogue Design Maps the Binding Conformation of Potent <i>N</i>-Benzylphenethylamine 5-HT<sub>2A</sub> Serotonin Receptor Agonist Ligands by Jose I. Juncosa, Martin Hansen, Lisa A. Bonner, Juan Pablo Cueva, Rebecca L. Maglathlin, John D. McCorvy, Danuta Marona‐Lewicka, Markus A. Lill, David E. Nichols
Published 2012Artigo -
15
The G Protein–Biased <i>κ</i>-Opioid Receptor Agonist RB-64 Is Analgesic with a Unique Spectrum of Activities In Vivo by Kate L. White, J. Elliott Robinson, Hu Zhu, Jeffrey F. DiBerto, Prabhakar R. Polepally, Jordan K. Zjawiony, David E. Nichols, C. J. Malanga, Bryan L. Roth
Published 2014Artigo -
16
Return of the lysergamides. Part II: Analytical and behavioural characterization of <i>N</i><sup>6</sup>‐allyl‐6‐norlysergic acid diethylamide (AL‐LAD) and (2’<i>S</i>,4’<i>S</i>)‐... by Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal, Simon Elliott, Jason Wallach, Tristan Colestock, Timothy E. Burrow, Stephen J. Chapman, Alexander Stratford, David E. Nichols, Adam L. Halberstadt
Published 2016Artigo -
17
Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM‐775) by Simon D. Brandt, Pierce V. Kavanagh, Brendan Twamley, Folker Westphal, Simon Elliott, Jason Wallach, Alexander Stratford, Landon M. Klein, John D. McCorvy, David E. Nichols, Adam L. Halberstadt
Published 2017Artigo -
18
Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor by Kuglae Kim, Tao Che, Ouliana Panova, Jeffrey F. DiBerto, Jiankun Lyu, B. Krumm, Daniel Wacker, Michael J. Robertson, Alpay B. Seven, David E. Nichols, Brian K. Shoichet, Georgios Skiniotis, Bryan L. Roth
Published 2020Artigo -
19
-
20
Ligand and G-protein selectivity in the κ-opioid receptor by Jianming Han, Jingying Zhang, Antonina L. Nazarova, Sarah M. Bernhard, B. Krumm, Lei Zhao, Jordy Homing Lam, Vipin A. Rangari, Susruta Majumdar, David E. Nichols, Vsevolod Katritch, Peng Yuan, Jonathan F. Fay, Tao Che
Published 2023Artigo
Search Tools:
Related Subjects
Receptor
Pharmacology
Chemistry
Biochemistry
Biology
Neuroscience
Hallucinogen
Serotonin
Medicine
Agonist
Psychology
Stereochemistry
Lysergic acid diethylamide
Psychiatry
5-HT receptor
Dopamine
Functional selectivity
G protein-coupled receptor
Internal medicine
Chromatography
Cognition
Drug
High-performance liquid chromatography
Mescaline
Partial agonist
Psilocybin
Serotonin Antagonists
5-HT2 receptor
Anxiety
Catalysis